Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.

BACKGROUND: Multiple sclerosis results from T-cell-dependent inflammatory demyelination of the central nervous system. Our objective was long-term suppression of inflammation with short-term monoclonal antibody treatment. METHODS: We depleted 95% of circulating lymphocytes in 27 patients with multi...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Coles, A, Wing, M, Smith, S, Coraddu, F, Greer, S, Taylor, C, Weetman, A, Hale, G, Chatterjee, V, Waldmann, H, Compston, A
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	1999

Eitemau Tebyg

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
gan: Coles, A, et al.
Cyhoeddwyd: (1999)

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.
gan: Coles, A, et al.
Cyhoeddwyd: (2006)

Monoclonal antibodies as agents to reinduce tolerance in autoimmunity.
gan: Waldmann, H, et al.
Cyhoeddwyd: (1992)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
gan: Lim, S, et al.
Cyhoeddwyd: (1993)

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
gan: Moreau, T, et al.
Cyhoeddwyd: (1996)

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
gan: Isaacs, J, et al.
Cyhoeddwyd: (1997)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
gan: Isaacs, J, et al.
Cyhoeddwyd: (1998)

Advantages of rat monoclonal antibodies.
gan: Clark, M, et al.
Cyhoeddwyd: (1983)

Safety and tolerability of anti-FcRn monoclonal antibody in thyroid autoimmunity
gan: Jan Wolf, et al.
Cyhoeddwyd: (2024-06-01)

Specificity of monoclonal antibody Campath-1.
gan: Hale, G, et al.
Cyhoeddwyd: (1988)

Monoclonal antibodies in multiple sclerosis treatment: current and future steps
gan: Claire L. Helliwell, et al.
Cyhoeddwyd: (2009-07-01)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
gan: Hale, G, et al.
Cyhoeddwyd: (1994)

BIOLOGICAL EFFECTS OF A HUMAN IGG4 MONOCLONAL-ANTIBODY IN-VIVO
gan: Isaacs, J, et al.
Cyhoeddwyd: (1995)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
gan: Waldmann, H, et al.
Cyhoeddwyd: (2001)

Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis.
gan: Flynn, J, et al.
Cyhoeddwyd: (1989)

MONOCLONAL-ANTIBODIES TO HEMATOPOIETIC-CELLS
gan: Waldmann, H, et al.
Cyhoeddwyd: (1982)

Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
gan: Coles, A, et al.
Cyhoeddwyd: (2003)

Interaction of rat monoclonal antibodies with human killer cells.
gan: Clark, M, et al.
Cyhoeddwyd: (1985)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
gan: Bindon, C, et al.
Cyhoeddwyd: (1985)

CAMPATH-IH in multiple sclerosis.
gan: Moreau, T, et al.
Cyhoeddwyd: (1996)

ALTERED DEVELOPMENT OF ADOPTIVELY TRANSFERRED EXPERIMENTAL AUTOIMMUNE-THYROIDITIS (EAT) BY RAT MONOCLONAL-ANTIBODIES (MAB) TO L3T4 AND LYT-2 ANTIGENS
gan: Flynn, J, et al.
Cyhoeddwyd: (1988)

Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody.
gan: Nabozny, G, et al.
Cyhoeddwyd: (1991)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
gan: Cox, A, et al.
Cyhoeddwyd: (2005)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
gan: Bindon, C, et al.
Cyhoeddwyd: (1988)

Monoclonal antibodies in the treatment of autoimmune diseases
gan: Jesús Emiliano García Aguilar
Cyhoeddwyd: (2023-09-01)

Monoclonal antibodies for immunosuppression.
gan: Waldmann, H, et al.
Cyhoeddwyd: (1988)

Antipolyphosphate monoclonal antibodies derived from autoimmune mice
gan: Josepha C. Sedzro, et al.
Cyhoeddwyd: (2024-08-01)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
gan: Dyer, M, et al.
Cyhoeddwyd: (1988)

THE USE OF MONOCLONAL ANTILYMPHOCYTE ANTIBODIES IN CLINICAL IMMUNOSUPPRESSION
gan: Friend, P, et al.
Cyhoeddwyd: (1985)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
gan: Isaacs, J, et al.
Cyhoeddwyd: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
gan: Kyle, V, et al.
Cyhoeddwyd: (1991)

Monoclonal-antibody therapy in systemic vasculitis.
gan: Mathieson, P, et al.
Cyhoeddwyd: (1990)

INTERACTION OF RAT MONOCLONAL-ANTIBODIES WITH HUMAN KILLER CELLS (K-CELLS)
gan: Hale, G, et al.
Cyhoeddwyd: (1984)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
gan: Hale, G, et al.
Cyhoeddwyd: (1989)

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.
gan: Hale, G, et al.
Cyhoeddwyd: (1985)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
gan: Isaacs, J, et al.
Cyhoeddwyd: (1996)

MONOCLONAL ANTIBODY FOR MULTIPLE SCLEROSIS TREATMENT
gan: E. V. Popova
Cyhoeddwyd: (2017-05-01)

Monoclonal antibodies in development in multiple sclerosis
gan: J. Sastre-Garriga, et al.
Cyhoeddwyd: (2011-11-01)

Monoclonal Antibodies for Multiple Sclerosis Treatment
gan: Filipe Palavra
Cyhoeddwyd: (2015-09-01)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
gan: Waldmann, H, et al.
Cyhoeddwyd: (1985)